Analysis of information sources in references of the Wikipedia article "Ita Wegman" in English language version.
Available evidence from well-designed clinical trials does not support claims that mistletoe can improve length or quality of life.
Although mistletoe was found to be therapeutically effective in most of the reported studies, many of the studies had one or more major design weaknesses as mentioned above that raised doubts about the reliability of the findings. These weaknesses include the following:
Mistletoe has been used to treat cancer patients for a century, and this era, which has been mostly one of therapeutic impotence, is now ending. ... In the 1920s, the New England Journal of Medicine published multiple articles on the treatment of hypertension with mistletoe extracts (12), but, as the pathophysiology of hypertension became clearer and effective treatments for it were developed, mistletoe disappeared from cardiovascular medicine. Something similar may well happen in the domain of oncology.
Mistletoe has been used to treat cancer patients for a century, and this era, which has been mostly one of therapeutic impotence, is now ending. ... In the 1920s, the New England Journal of Medicine published multiple articles on the treatment of hypertension with mistletoe extracts (12), but, as the pathophysiology of hypertension became clearer and effective treatments for it were developed, mistletoe disappeared from cardiovascular medicine. Something similar may well happen in the domain of oncology.
Mistletoe has been used to treat cancer patients for a century, and this era, which has been mostly one of therapeutic impotence, is now ending. ... In the 1920s, the New England Journal of Medicine published multiple articles on the treatment of hypertension with mistletoe extracts (12), but, as the pathophysiology of hypertension became clearer and effective treatments for it were developed, mistletoe disappeared from cardiovascular medicine. Something similar may well happen in the domain of oncology.
